Member Info for PM2022

https://www.turnerpope.com/investor-evenings/webinars/

Can everyone watch the presentation from 54 min onwards so at the last minute or two.

Suzy is expecting progress on evaluations
Suzy is expecting progress on legacy assets
Suzy is expecting revenue

Both Suzy and Stella seem very confident on the 201 deal in every presentation.

The way I see this play out. It does look like Barcelona will be successful then we should get either 201 deal or 301 moving into full preclinical very shortly which itself would be huge given that it is for endometriosis or both before June. Also Hakkaido due in June and we should get updates regarding the lab. Later in the year CLX update would be huge and even on its own would probably be worth at least 20 million with another positive date update.

I really don't see why we cannot easily get to 50 million market cap in the short term. We have been to 74p and 65p based on nothing on 201 but now we have everything and a completed deal should see a strong sentiment turn. This is a strong buy level.

Remember when a compound goes into SPV the minimum estimated worth is at least 10 million. We already have CLX and a lab everything is priced at zero including potential. So 50p imo would be at the bottom end if you work it out with positive outcomes that Suzy is talking about. Make up your own minds.

These are the times to buy. DYOR.

I think Kevin and Suzy have an interest of about 800k-1 million shares each. About 400-500k shares each and about 500k share options at 30/40p. Might not be huge but it is a fairly significant amount in total to not want to screw themselves up. I would assume they are more than happy with that amount.

Stella is already very wealthy so I would ignore her but obviously would have been good but makes no difference. Probably does not want to spike the share because she is buying because she can buy the lot if she wanted. She is just here to give advice.

As I said yesterday I ignored your posts until you initiated on this occasion yesterday. I post about the stock but your posting history tells a different story targeting anyone with a positive view once you have sold. Later for now.

BTW I don't hold 1k like you. My average is all that matters and I have purchased a fair amount since last year at 10p range and purchased mainly below 20p 2 years ago therefore very low average. I even purchased 60k shares this week alone below 10p.

Unless you can prove my average then don't waste your time. It's obvious certain individuals target certain others as they hold sold and with research you can make your own judgment as to the value of our products and where we should be. Lots of news is due so take it or leave it but highly unlikely you will get it cheaper.

Maybe I should post my false down post but I'll leave that for later. Value on offer enjoy your weekend. I'll be back.

BTW I don't hold 1k like you. My average is all that matters and I have purchased a fair amount since last year at 10p range and purchased mainly below 20p 2 years ago therefore very low average. I even purchased 60k shares this week alone below 10p.

Unless you can prove my average then don't waste your time. It's obvious certain individuals target certain others as they hold sold and with research you can make your judgment as to the value of our products and where we should be. Lots of news is due so take it or leave it but highly unlikely you will not get it cheaper.

Maybe I should post my false down post but I'll leave that for later. Value on offer enjoy your weekend. I'll be back.

My only assumption is that you have already sold after buying at 11p. Now I say you can never make money because really the truth is don't have balls. Soon as you buy and it goes down you want to sell when it breaks even. That is obviously a sign of a complete novice which you are.

No I do not recall buying above 30p. At 30p I was massively in profit and at 50,60p as well. Do you even know how much I have so pointless making assumptions because one can add anywhere like I have been at these prices. I rest my case.

Lockdown I ignore your posts. Buy at 11p watch it go to 9p and sell at 11p seems to be your pattern. Not exactly the smartest investor here are you. You purchase a few K and hope to just get your money back every time. You will never make money mark my words on that.

BTW my average is only slightly higher than the current SP.

Easy 5-10 bagger over the next 12 months. Buy when others are fearful but not sure what the fear is.

CLX is already worth way more than our mc. An update with data in the next few months will be worth at least 2-3 times our mc at this price with a potential deal. Then obviously 201 should get done at some point you would imagine before June. 301 they have been working on it for 3 years and I heard it was looking positive.

Lab updates and contracts and outcomes of evaluation projects giving us a bigger preclinical pipeline. Easiest multibagger on AIM for years IMO. Also the sector biotec is likely to do well due to government initiatives. We all know we should be at least 25-30p at the moment.

Exactly would rather it comes with other news. No point watching it go to 15p then down again when we should be worth so much more. She needs to build momentum. I also said I think it will come with 201 so time will tell.

Watch this space. When news comes momentum will be strong. Very low price, well funded plus booking sector to come. Fireworks all the way.

"The government were basically saying 'we care about life sciences' but pulling away one of the greatest levers that we had to attract investment," said Iain McGill, CEO of London-based Quell Therapeutics, referring to last year's changes.

"So this coming back ... is a real lifeline."

There are about 6,548 businesses in the UK life sciences industry, of which 70%-80% are SMEs, government figures show.

Yes in Telegram and still invested.

Even with just CLX and lab we should be 20p so not selling at all. WIth 301 update, 201 deal and Hakkaido then you are looking at far more. See how it plays out.

Metom,

Confidence will return to the sector very soon. See below. Lots of investment will come into these biotechs. Management has been crap so far but I think we just need one or two decent outcomes and we will get that before June. I think Barcelona is a success and will come with 201 very soon. You can't have one RNS to keep the price high. Best to wait until June imo.

The government remains committed to supporting R&D and recognises the important role that R&D and innovation play for the economy and society. From 1 April 2023, the government will introduce an increased rate of relief for loss-making R&D intensive Small and Medium size Enterprises (SMEs). Eligible companies will receive £27 from HMRC for every £100 of R&D investment.

Steve Bates OBE, CEO of BioIndustry Association said:

This is a huge boost for biotech companies across the UK developing new medicines and improving healthcare for patients. Our research-intensive industry is a key growth area for Britain’s economy. The Chancellor is rightly focusing UK taxpayer support to enable life science entrepreneurs to crowd in more private investment, help keep the UK at the cutting-edge of international science, and create new high-value jobs across the UK.

Will Barcelona drop today? Who knows but it's due and besides so is 301, 201 news and lab updates. A nice RNS confirming cost savings and intentions just showing us that they do want the share price to go to fair value would be a great start.

Personally Barcelona is a dead cert for me. Two world class preclinical compounds and we should be no less than 30 p imo and that without 201 or lab contracts/potential.

Still only 10 million market cap. We have hardly moved up in terms of valuation.

With the start of the ISA year about two weeks ago and given how undervalued we are and the amount of news due once news comes we should have significant buying. It just takes a few £20k buys with a few bigger buys and we will be moving a decent amount.

Great to see we can claim so much cash back. Lots of positives and cash will flow into this sector over the coming weeks/months. We are rock bottom so what a buy at the moment.

Give it a week or two and I’m sure Suzy will reward you with a Big Mac for all your efforts.

Not needed until the end of the year very well funded. Also don't forget further cash from warrants at 14 p and revenue from the lab. By year end we can get a deal for CLX or we should get a value adding RNS regarding this that could increase SP by multiples. Also 201 should get done in the next few months believe it or not so therefore we will not be 9 p more like 30/40/50p and a raise of about 3 million at those prices is nothing.

The value is on offer for a huge rise with any decent news. She needs to focus on the RNS and maybe talk a little less about the science and more about potential/value/next steps in bullet point format.

At the end of the day the market needs to have a reason to see a return both short and long term so she needs to write a good RNS otherwise it's just constant failure by her.

We all know one news will not be enough at these prices. I am expecting 2/3 RNS within a week or two to hold the SP up and to build confidence.

Barcelona is highly likely to be successful as it takes time to get the announcement out through the university at the same time and it could well come with 201 soon after. If it was delayed or failed like previous compounds we likely would have already known.

Whatever happens everything has to fail for us to stay at these prices so a great risk to reward buy here.

My prediction is 0.29 close finish and 0.36 by Friday.